LungLife AI, Inc.
LLAI.L · LSE
6/30/2024 | 12/31/2023 | 6/30/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | -73.9% | 0% | 64.3% | – |
| Cost of Goods Sold | £0 | £0 | £0 | £0 |
| Gross Profit | £0 | £0 | £0 | £0 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | £0 | £1 | £0 | £2 |
| G&A Expenses | £2 | £3 | £3 | £4 |
| SG&A Expenses | £2 | £3 | £3 | £3 |
| Sales & Mktg Exp. | £0 | -£0 | £0 | -£0 |
| Other Operating Expenses | £0 | -£12 | £0 | £0 |
| Operating Expenses | £2 | -£9 | £3 | £3 |
| Operating Income | -£2 | £9 | -£3 | -£3 |
| % Margin | -31,666.7% | 37,134.8% | -12,647.8% | -23,378.6% |
| Other Income/Exp. Net | £0 | -£11 | £0 | £0 |
| Pre-Tax Income | -£2 | -£3 | -£3 | -£3 |
| Tax Expense | £0 | £0 | £0 | £0 |
| Net Income | -£2 | -£3 | -£3 | -£3 |
| % Margin | -31,016.7% | -11,330.4% | -12,204.3% | -22,407.1% |
| EPS | -0.066 | -0.102 | -0.11 | -0.123 |
| % Growth | 35.8% | 7.3% | 10.6% | – |
| EPS Diluted | -0.066 | -0.102 | -0.11 | -0.123 |
| Weighted Avg Shares Out | 28 | 25 | 25 | 25 |
| Weighted Avg Shares Out Dil | 28 | 25 | 25 | 25 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £0 | £0 |
| Interest Expense | £0 | £0 | £0 | £0 |
| Depreciation & Amortization | £0 | £0 | £0 | £0 |
| EBITDA | -£2 | -£3 | -£3 | -£3 |
| % Margin | -29,466.7% | -11,278.3% | -12,104.3% | -22,450% |